"The report and ad are part of what is becoming a deafening chorus of voices that believe FDA needs the help of external expertise when it comes to regulatory decision-making on biomarkers."—Sue Sutter, The Pink Sheet Daily, October 15, 2015
ERROR
Main Error Mesage Here
